Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6604035.pdf
Reference31 articles.
1. Benezra R, Rafii S, Lyden D (2001) The Id proteins and angiogenesis. Oncogene 20: 8334–8341
2. Coppe J, Itahana Y, Moore D, Bennington J, Desprez P (2004) Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res 10: 2044–2051
3. Desprez P, Lin C, Thomasset N, Sympson C, Bissell M, Campisi J (1998) A novel pathway for mammary epithelial cell invasion induced by the helix–loop–helix protein Id-1. Mol Cell Biol 18: 4577–4588
4. Fong S, Debs R, Desprez P (2004) Id genes and proteins as promising targets in cancer therapy. Trends Mol Med 10: 387
5. Fong S, Itahana Y, Sumida T, Singh J, Coppe J, Liu Y, Richards P, Bennington J, Lee N, Debs R, Desprez P (2003) Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci USA 100: 13543–13548
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ID2 promotes tumor progression and metastasis in thyroid cancer;Endocrine;2024-01-10
2. ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway;Frontiers in Cell and Developmental Biology;2021-10-22
3. Inhibitor of DNA Binding 2 (ID2): A Novel Marker for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma;Annals of Surgical Oncology;2021-03-30
4. Id1 and Id3 Are Regulated Through Matrix‐Assisted Autocrine BMP Signaling and Represent Therapeutic Targets in Melanoma;Advanced Therapeutics;2020-10-12
5. Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling;Frontiers in Oncology;2020-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3